4-Methylmorpholine → HCID 10237397, compound
Reaction equation
CN1CC[O:5]CC1.[F:8][C:9]1[CH:10]=[C:11]([N:22]2[CH2:26][C@H:25]([CH2:27][NH:28][C:29](=[O:31])[CH3:30])[O:24][C:23]2=[O:32])[CH:12]=[CH:13][C:14]=1[N:15]1[CH2:20][CH2:19][S:18](=[O:21])[CH2:17][CH2:16]1.FC(F)(F)C(OC(=O)C(F)(F)F)=O>C(Cl)Cl>[O:21]=[S:18]1(=[O:5])[CH:17]=[CH:16][N:15]([C:14]2[CH:13]=[CH:12][C:11]([N:22]3[CH2:26][C@H:25]([CH2:27][NH:28][C:29](=[O:31])[CH3:30])[O:24][C:23]3=[O:32])=[CH:10][C:9]=2[F:8])[CH2:20][CH2:19]1Participants
Procedure
4-Methylmorpholine (1.2 mL, 11.1 mmol) is added to a solution of N-[[(5S)-3-[3-fluoro-4-(1-oxido-4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide (0.690 g, 1.87 mmol; prepared as described in U.S. Pat. No. 5,688,792) in DCM (40 mL), followed by trifluoroacetic anhydride (1.06 mL, 7.5 mmol). The solution is stirred at r.t. for about 20 h, and is concentrated under vacuum, then dissolved in 100 mL of EtOAc—2.5% aq. NaHCO3 (1:1). Aqueous phase is extracted with EtOAc (2×50 mL). The combined organic layers are washed with brine, and dried (MgSO4). Solvent is removed under vacuum to afford the title compound that is used directly without further purification. Step 2: Preparation of N-[[(5S)-3-[4-[2,3-dihydro-1,1-dioxido-6-(trifluoroacetyl)-4H-1,4-thiazin-4-yl]-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide.
Workup
- customprepared
- concentrationis concentrated under vacuum
- dissolutiondissolved in 100 mL of EtOAc—2.5% aq. NaHCO3 (1:1)
- extractionAqueous phase is extracted with EtOAc (2×50 mL)
- washThe combined organic layers are washed with brine
- dry with materialdried (MgSO4)
- customSolvent is removed under vacuum
Sources & evidence
- ORD record
- ord-ced94a0375cd4636896613b77a97412e
- Source dataset
- uspto-grants-2005_04
- Patent number
- US06884813B2
Reaction notes
Loading…